Work

A Phase I Trial of the Histone Deacetylase (HDAC) Inhibitor, Panobinostat, in Combination with Lenalidomide in Patients with Relapsed/Refractory Hodgkin's Lymphoma (HL)

Year: 2012

Type: article

Source: Blood

DOI: 10.1182/blood.v120.21.1644.1644

Authors: Beth Christian, Anne Kopko, Todd A. Fehniger, Nancy L. Bartlett, Kristie A. Blum

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Washington University in St. Louis

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2497895663

FWCI: 1.042

Cites:

Cited by: 10

Related to: 10